Study guide
Respiratory, Cardiovascular, Neurologic, and Musculoskeletal Symptoms
OCN Oncology Certified Nurse Study Guide Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: OCN Exam Orientation and Official Source Control
Official Sources and Credential Purpose Eligibility, Application, and Fees Exam Format, Scoring, Blueprint, and Generic Drugs PSI Scheduling, ATT, Test Day, and Results Blueprint-Based Study Plan and Readiness
2 Chapter 2: Care Continuum, Prevention, Survivorship, and End-of-Life Care
Health Promotion, Risk Reduction, and Epidemiology Screening, Early Detection, and High-Risk Referrals Navigation, Coordination, and Care Continuity Palliative Care, Advance Care Planning, and Goals Survivorship, Rehabilitation, Recurrence, and Late Effects Sexuality, Family Support, Discrimination, and Social Needs End-of-Life Care, Hospice, Bereavement, and Comfort Measures
3 Chapter 3: Oncology Science and Site-Specific Cancer Assessment
Carcinogenesis, Immunology, and Cancer Biology Genomic, Genetic Testing, and Biomarker Literacy Clinical Trials, Research Protocols, and Informed Participation Diagnostic Workup, Biopsy, Imaging, and Pathology Basics Staging, Grading, Prognosis, and Performance Status Common Cancer Patterns and Metastatic Sites Oncology Assessment, Data Clustering, and Escalation
4 Chapter 4: Professional Oncology Nursing Practice, Safety, and Standards
Scope, Standards, Nursing Process, and Documentation Collaboration, Communication, and Interprofessional Practice Safe Handling, PPE, Occupational Health, and Exposure Response Culturally Congruent Care, Advocacy, and Ethics Self-Care, Compassion Fatigue, Burnout, and Professional Development
5 Chapter 5: Treatment Modalities I - Surgery, Radiation, Transplant, Localized and Oral Therapy
Surgery and Procedural Oncology Nursing Care Radiation Therapy Principles, Toxicities, and Teaching Blood and Marrow Transplant Foundations Localized Therapy: Intrathecal, Intravesical, and Regional Care Oral Oncology Therapy Adherence, Safety, and Education Treatment Sequencing, Response Monitoring, and Care Coordination Modality-Specific Patient Teaching and Documentation
6 Chapter 6: Treatment Modalities II - Systemic Therapy, Immunotherapy, and Targeted Agents
Chemotherapy Foundations and Infusion Safety Biotherapy, Immunotherapy, and Immune-Related Adverse Events Targeted Therapy, Immune Cell, and Bispecific Antibody Basics Hormonal Therapy and Endocrine Cancer Treatment Considerations Vascular Access, Infusion Monitoring, and Extravasation Prevention Systemic Therapy Patient Education and Home Safety Therapy Response, Adherence, and Toxicity Escalation
7 Chapter 7: Symptom Management and Supportive Care
Symptom Assessment, Toxicity Grading, and Prioritization Hematologic, Immunologic, and Infection Supportive Care GI, GU, Nutrition, and Hydration Supportive Care Integumentary, Ostomy, Lymphedema, and Wound Care Respiratory, Cardiovascular, Neurologic, and Musculoskeletal Symptoms Pain Management, Pharmacologic, and Integrative Care Vascular Access Device Care and Supportive Care Coordination
8 Chapter 8: Oncologic Emergencies and Rapid Escalation
Sepsis, SIRS, Neutropenic Infection, and Shock Tumor Lysis, Hypercalcemia, SIADH, and Metabolic Emergencies Hypersensitivity, Anaphylaxis, and Infusion Reactions Spinal Cord Compression, SVC Syndrome, Increased ICP, and Obstructions DIC, VTE, Bleeding, and Thrombotic Emergencies Pneumonitis, Extravasation, and Local Therapy Emergencies Immune-Related Emergencies, CRS, ICANS, and Urgent Triage
9 Chapter 9: Psychosocial Dimensions of Oncology Care
Distress Screening, Emotional Response, and Crisis Care Cultural, Spiritual, Religious, and Language-Responsive Care Family, Caregiver Support, and Shared Decision-Making Sexuality, Fertility, Gender, and Body Image Concerns Learning Barriers, Health Literacy, and Patient Education Financial Toxicity, Support Systems, and Resource Referrals
10 Chapter 10: Mixed OCN Case Labs
New Diagnosis Navigation and Treatment Planning Case Lab Chemotherapy Infusion Reaction and Extravasation Case Lab Immunotherapy Toxicities and CRS ICANS Case Lab Radiation Surgery and Localized Therapy Case Lab Symptom Management Neutropenia Pain and Nutrition Case Lab Oncologic Emergency TLS SVC Cord Compression Case Lab Survivorship Palliative Psychosocial and Discharge Case Lab
11 Chapter 11: Final Review, High-Yield Tables, and OCN Exam-Day Readiness
Blueprint Quick Reference and Domain Triage High-Yield Oncology Safety and Emergency Tables Generic Drug Stems, Labs, and Supportive Care Patterns Final Week Practice Plan, Error Log, and Stamina Final 48 Hours, PSI Test Day, and Retake Planning
Respiratory, Cardiovascular, Neurologic, and Musculoskeletal Symptoms
Key Takeaways Explain This Topic AI
New respiratory symptoms during immunotherapy or thoracic radiation may be pneumonitis; sudden pleuritic dyspnea with tachycardia suggests pulmonary embolism, a frequent cancer complication.
Anthracyclines (doxorubicin) carry a cumulative dose-related cardiomyopathy risk (roughly above 450-550 mg/m2 for doxorubicin); trastuzumab causes reversible LV dysfunction, monitored by serial ejection fraction.
New back pain with leg weakness, numbness, saddle anesthesia, or bowel/bladder change is spinal cord compression, an emergency requiring immediate MRI and corticosteroids.
Chemotherapy-induced peripheral neuropathy (platinums, taxanes, vinca alkaloids, bortezomib) is assessed by function and fall risk, not sensation alone.
Cancer-related fatigue is the most prevalent symptom and may not fully resolve with rest; screen for anemia, sleep, pain, depression, and endocrine causes.
Last updated: October 2026
- Respiratory, Cardiovascular, Neurologic, and Musculoskeletal Symptoms
- Respiratory Assessment
Respiratory symptoms demand focused triage because the cause may be infectious, treatment-related, thrombotic, structural, or malignant. Assess onset, work of breathing, SpO2, respiratory rate, cough, sputum, fever, chest pain, wheeze, hemoptysis, orthopnea, and activity tolerance.
Tie the picture to therapy: new dyspnea during neutropenia may be pneumonia or sepsis; a new cough or dyspnea after thoracic radiation or checkpoint-inhibitor therapy may be pneumonitis (an irAE treated with steroids, not antibiotics alone); sudden pleuritic chest pain with tachycardia and hypoxia suggests pulmonary embolism (PE) , which is markedly more common in cancer due to a hypercoagulable state.
- Symptom cluster Likely concern RN priority
- Fever, cough, neutropenia Infection or sepsis Urgent evaluation, cultures + antibiotics as ordered
- Sudden pleuritic dyspnea, tachycardia Pulmonary embolism Emergency escalation, oxygen, anticoagulation workup
- New cough after immunotherapy Pneumonitis vs infection Hold assumptions, notify team, anticipate steroids
- Orthopnea, edema, weight gain Heart failure / fluid overload Vitals, oxygenation, cardiac history
Supportive actions: positioning, protocol oxygen, monitoring, energy conservation. In palliative settings, dyspnea care includes a bedside fan , low-dose opioids, and anxiety support.
Cardiovascular Symptoms and Cardiotoxicity
Know the cardiotoxic agents. Anthracyclines (doxorubicin) cause cumulative, dose-related cardiomyopathy; risk rises notably above a lifetime doxorubicin dose of roughly 450-550 mg/m2 , and dexrazoxane may be cardioprotective. Trastuzumab (HER2) causes usually reversible left-ventricular dysfunction, monitored by serial ejection fraction (echo or MUGA) . Other risks: VEGF/TKI hypertension, QT prolongation, and immune myocarditis. Cancer also raises venous thromboembolism risk.
Escalate chest pain, new severe dyspnea, syncope, symptomatic hypotension, uncontrolled hypertension, a new symptomatic irregular rhythm, unilateral calf swelling, or stroke signs. Teach reporting of swelling, sudden weight gain, calf pain, and chest symptoms, and adherence to antihypertensives and anticoagulants.
Neurologic Red Flags
Neurologic symptoms arise from brain metastases, spinal cord compression , chemo-induced neuropathy, ICANS, metabolic shifts, or stroke. The classic emergency: new back pain with leg weakness, numbness, saddle anesthesia, or bowel/bladder dysfunction points to spinal cord compression, requiring immediate MRI and urgent corticosteroids (dexamethasone) when there are neurologic deficits, to preserve function. Confusion after CAR-T or bispecific therapy suggests ICANS; severe headache with thrombocytopenia raises intracranial bleeding concern.
Chemotherapy-induced peripheral neuropathy (CIPN) is caused by platinums (cisplatin, oxaliplatin), taxanes, vinca alkaloids, and bortezomib . Assess function, not just sensation: can the patient button clothes, feel the floor, use stairs, drive, or handle hot objects safely? Interventions: fall precautions, footwear advice, and physical/occupational therapy referral. Oxaliplatin uniquely causes cold-triggered acute neuropathy, so teach cold avoidance.
Musculoskeletal Function, Fatigue, and Falls
Musculoskeletal symptoms include arthralgia, myalgia, steroid myopathy, deconditioning, and bone metastases that risk pathologic fracture, hypercalcemia, and cord compression . Assess pain, movement effect, neuro changes, gait, and calcium symptoms. Cancer-related fatigue is the most prevalent oncology symptom, is distinct from ordinary tiredness, and often does not fully resolve with rest; evaluate anemia, sleep, pain, depression, medications, nutrition, and endocrine and infectious causes. Teach pacing, planned activity, and energy conservation, and revisit home-safety needs after every fall or near-fall.
Reassessment asks whether function improved, not only whether a number changed.
Distinguishing Treatment Effect From Emergency
The hardest OCN reasoning is separating an expected side effect from an emergency that shares the same words. Mild dyspnea on exertion that improves with rest in an anemic patient is different from dyspnea at rest with hypoxia and pleuritic pain, which is a possible PE. Tingling fingertips early in taxane therapy differ from ascending weakness with gait change, which threatens function. A dull steady backache differs from new, severe, band-like back pain with leg weakness. The nurse uses a few sorting questions: Is the symptom new or rapidly worsening? Does it occur at rest? Are there neurologic, cardiopulmonary, or perfusion changes?
Is it consistent with a known emergency pattern for this patient's disease and drugs? When the answer trends toward instability, the nurse acts first and grades later, because in oncology the cost of underreacting to cord compression, PE, or sepsis is far higher than the cost of an early evaluation.
Cardiac Surveillance and Functional Rehabilitation
Cardio-oncology surveillance is increasingly tested. Patients on anthracyclines or trastuzumab get a baseline ejection fraction and periodic re-checks, and the nurse reinforces why a missed echo or MUGA appointment matters and teaches early heart-failure reporting: ankle swelling, sudden weight gain of more than 2-3 lb in a day or 5 lb in a week, orthopnea, and a new cough. On the functional side, oncology rehabilitation is an active intervention, not an afterthought.
Physical therapy rebuilds strength, balance, and endurance; occupational therapy restores fine-motor function and energy-conserving routines; and early referral can prevent the deconditioning spiral that ends in falls and treatment delays. The nurse screens for stairs, assistive-device use, driving safety, and caregiver availability, then closes the loop by confirming that referrals occurred and that the patient is measurably steadier, stronger, and safer after the plan was put in place rather than simply reporting a lower symptom score on paper.
Throughout, the nurse resists dismissing fatigue as laziness or attributing every new symptom to the cancer itself, because reversible drivers such as anemia, hypothyroidism, depression, sleep disruption, and medication effects are common and treatable when actively sought.